Business
Press Release Aug 31 2023
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated August 31, 2023, titled "Zydus receives final approval from the USFDA for Isotretinoin Capsules USP, 10 mg, 20 mg 30 mg and 40 mg".
About this update from Zydus Lifesciences Limited
[{"type":"text","content":" Zydus Lifesciences Limited has informed the Exchange regarding a press release dated August 31, 2023, titled \"Zydus receives final approval from the USFDA for Isotretinoin Capsules USP, 10 mg, 20 mg 30 mg and 40 mg\". View Attachment","length":370,"tagName":"div"}]